Drug for Treatment of Colon Cancer
US 8,329,756 and US 8,518,990, assigned to Oncophor LLC, cover the discovery of two new chemicals that can be used for the treatment, prevention, or amelioration of hyperproliferative diseases and/or disorders such as colon cancer, and are available for sale through IPApproach.
- US Patents
- 2 granted
- Assignee
- Oncophor LLC
- Availability
- For Sale
Patents Included
Technology Highlights
- It provides a method for treating, preventing, or ameliorating a hyperproliferative disease and/or disorder such as cancer with minimal or none of the side effects often associated with chemotherapy.
- It provides a method of not killing normal reproducing cells while treatment.
- The method helps to inhibit cancer cell proliferation and demonstrates significant absence of side effects, low toxicity, superior bioavailability in general (such as e.g. good internal absorption), superior therapeutic window and beneficial effects related to their therapeutic and pharmaceutical suitability.
- Utilizing the compounds specified in the method helps to avoid side effects from chemotherapy including, gastrointestinal toxicity such as early and late-forming diarrhea and flatulence; nausea; vomiting; anorexia; leukopenia; anemia; neutropenia; asthenia; abdominal cramping; fever; pain; loss of body weight; dehydration; alopecia; dyspnea; insomnia; dizziness, mucositis, xerostomia, and kidney or renal failure, as well as constipation, nerve and muscle effects, temporary or permanent damage to kidneys and bladder, flu-like symptoms, fluid retention, and temporary or permanent infertility.
Overview
IPApproach, LLC is pleased to present the exclusive patents for sale "Drug For Treatment Of Colon Cancer" which includes U.S. Granted Patents US 8,329,756 B2 & US 8,518,990 B2 assigned to Oncophor LLC. The IP relates to the discovery of two new chemicals that can be used for the treatment, prevention, or amelioration of hyperproliferative diseases and/or disorders such as colon cancer. The technology disclosed provides the following advantages:
Request the Brokerage Marketing Package
Contact Justin Ehrlickman for full documentation, claim charts, and pricing on this opportunity.
Listing updated August 21, 2026
IPApproach lists patents and portfolios where the seller has not requested anonymity or confidentiality. Patent numbers link to public records on Google Patents.